Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.000
-0.045 (-4.31%)
At close: Jan 30, 2026, 4:00 PM EST
1.010
+0.010 (1.00%)
After-hours: Jan 30, 2026, 7:50 PM EST
Allarity Therapeutics Market Cap
Allarity Therapeutics has a market cap or net worth of $17.36 million as of January 30, 2026. Its market cap has increased by 287.78% in one year.
Market Cap
17.36M
Enterprise Value
1.86M
1-Year Change
287.78%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since December 21, 2021, Allarity Therapeutics's market cap has decreased from $79.38M to $17.36M, a decrease of -78.12%. That is a compound annual growth rate of -30.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 18.15M | -3.24% |
| Dec 31, 2025 | 18.75M | 261.53% |
| Dec 31, 2024 | 5.19M | 106.50% |
| Dec 29, 2023 | 2.51M | -40.12% |
| Dec 30, 2022 | 4.20M | -94.65% |
| Dec 31, 2021 | 78.43M | -1.20% |
| Dec 21, 2021 | 79.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 19.29M |
| Lexaria Bioscience | 18.92M |
| Jupiter Neurosciences | 18.89M |
| Lunai Bioworks | 18.76M |
| VYNE Therapeutics | 18.61M |
| Quantum BioPharma | 18.44M |
| Traws Pharma | 17.58M |
| BioAtla | 16.46M |